Time to Refine Prostate Cancer Epidemiology: Defining New Endpoints for Effective Screening and Causal Epidemiological Studies.
作者信息
Cussenot Olivier, Rouprêt Morgan, Shariat Shahrokh F
机构信息
Department of Urology, Medical University of Vienna, Vienna, Austria.
Department of Urology, Hôpital Pitié-Salpétrière, AP-HP, Sorbonne University, Paris France.
出版信息
Eur Urol Oncol. 2025 Feb;8(1):7-8. doi: 10.1016/j.euo.2024.12.004. Epub 2024 Dec 24.
PMID:39721830
Abstract
Current epidemiological indicators reflect the prevalence of prostate-specific antigen (PSA) testing rather than the actual incidence of clinically significant prostate cancer. These indicators are also biased because of the variability of the PSA test. We therefore need to adopt new reliable criteria in causal epidemiological studies and screening programs.
摘要
Zotero 插件